| Mrs Kara Harrington Brennan, MSN, ARNP-BC | |
|
11522 Ne 20th St, Bellevue, WA 98004-3005 | |
| (425) 462-2531 | |
| (425) 454-6176 |
| Full Name | Mrs Kara Harrington Brennan |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Adult Health |
| Location | 11522 Ne 20th St, Bellevue, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003245432 | NPI | - | NPPES |
| 1003245432 | Medicaid | WA | |
| G8927771 | Other | MEDICARE PTAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LA2200X | Nurse Practitioner - Adult Health | AP60427017 (Washington) | Primary |
| 364SG0600X | Clinical Nurse Specialist - Gerontology | AP60427017 (Washington) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Kara Harrington Brennan, MSN, ARNP-BC 1520 Eastlake Ave E Apt 324, Seattle, WA 98102-3942 Ph: (303) 704-2270 | Mrs Kara Harrington Brennan, MSN, ARNP-BC 11522 Ne 20th St, Bellevue, WA 98004-3005 Ph: (425) 462-2531 |
News Archive
Quality Systems, Inc. ("QSI"), a leading provider of healthcare information systems and connectivity solutions, today announced that QSI has entered into an agreement to acquire Opus Healthcare Solutions, Inc.
Naurex Inc., a clinical stage company developing innovative treatments for depression and other CNS disorders, today reported that its clinical stage candidate for the treatment of depression, GLYX-13, and its second-generation NRX-1050 series have been selected for inclusion on Windhover's list of the "Top 10 Most Interesting Neuroscience Projects to Watch."
Stroke and myocardial infarction (MI) are a significant cause of death and disability worldwide. However, over the past several decades because of advances in medicines (thrombolytic agents, antiplatelet drugs, beta blockers, and angiotensin converting enzyme inhibitors) and approaches to restore tissue perfusion (percutaneous coronary intervention and cardiopulmonary bypass), the mortality of MI has declined dramatically.
Genaissance Pharmaceuticals today announced results from its CARING (Clozapine and Agranulocytosis Relationships Investigated by Genetics) study, reporting the discovery of genetic markers that the Company believes predict who is at risk of developing clozapine-induced agranulocytosis
› Verified 9 days ago
Ms. Jessica Swenson, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1231 116th Ave Ne, Suite 950, Bellevue, WA 98004 Phone: 425-454-3366 Fax: 425-460-5954 | |
Dr. Ambera Dedic, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1231 116th Ave Ne Ste 400, Bellevue, WA 98004 Phone: 425-289-3199 | |
Keenan Smith, PMHNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2105 112th Ave Ne Ste 201, Bellevue, WA 98004 Phone: 425-968-5948 | |
Leslie Elaine Smith, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1600 116th Ave Ne, Suite #102, Bellevue, WA 98004 Phone: 425-454-5311 Fax: 425-454-8188 | |
Hana K Ryan, AGPCNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 11695 Ne 4th St, Bellevue, WA 98004 Phone: 425-637-1855 Fax: 425-344-7970 | |
Thomas Chan, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 15585 Ne 24th St, Bellevue, WA 98007 Phone: 888-227-3312 |